ʻO ka antibiotic maʻamau,amoxicillin-clavulanate, hiki ke hoʻomaikaʻi i ka hana o ka ʻōpū liʻiliʻi i nā keiki e ʻike ana i nā haunaele motility, e like me kahi noiʻi i puka ʻia ma ka paʻi paʻi Iune o ka Journal of Pediatric Gastroenterology and Nutrition from Nationwide Children's Hospital.
ʻO Amoxicillan-clavulanate, i ʻike ʻia ʻo Augmentin, ka mea maʻamau i kuhikuhi ʻia e mālama a pale i nā maʻi i hoʻokumu ʻia e ka bacteria.Eia nō naʻe, ua hōʻike ʻia hoʻi e hoʻonui i ka neʻe ʻana o ka ʻōpū liʻiliʻi i nā poʻe olakino a ua hoʻohana ʻia e mālama i ka ulu ʻana o ka maʻi bacterial i nā maʻi me ka maʻi maʻi maʻi.
ʻO nā hōʻailona o ka ʻōpū o luna e like me ka nausea, ka luaʻi ʻana, ka ʻeha o ka ʻōpū, ka māʻona mua a me ka ʻoki ʻana o ka ʻōpū i nā keiki.ʻOiai ka holomua o ka ʻenehana no ka ʻike ʻana i nā maʻi motility, ke hoʻomau nei ka nele o nā lāʻau i loaʻa no ka mālama ʻana i ka hana kaʻa o ka ʻōpū o luna.
"He mea nui ka pono o nā lāʻau lapaʻau hou e mālama i nā hōʻailona o ka maʻi gastrointestinal i nā keiki," wahi a Carlo Di Lorenzo, MD, ke poʻo o Gastroenterology, Hepatology and Nutrition ma Nationwide Children's Hospital a me kekahi o nā mea kākau."Loaʻa pinepine nā lāʻau lapaʻau i hoʻohana ʻia i kēia manawa ma ke kumu i kaupalena ʻia, loaʻa nā hopena ʻaoʻao koʻikoʻi a ʻaʻole lawa ka maikaʻi ma ka ʻōpū liʻiliʻi a nui."
No ka nānā ʻana inā hiki i ka amoxicillin-clavulanate ke lilo i koho hou no ka mālama ʻana i ka hana kaʻa o ka ʻōpū o ka ʻōpū o luna, ua nānā nā mea noiʻi ma Nationwide Children's 20 mau mea maʻi i hoʻonohonoho ʻia e hana i ka hoʻāʻo antroduodenal manometry.Ma hope o ka hoʻokomo ʻana i ka catheter, nānā ka hui i ka motility o kēlā me kēia keiki i ka wā hoʻokē ʻai no ʻekolu mau hola.A laila ua loaʻa i nā keiki hoʻokahi maʻi oamoxicillin-clavulanatehoʻokahi hola ma mua o ka ʻai ʻana a i ʻole hoʻokahi hola ma hope o ka ʻai ʻana a laila nānā ʻia ka motility no hoʻokahi hola ma hope.
Ua hōʻike ka haʻawina i kēlāamoxicillin-clavulanateʻO nā pūʻulu o nā ʻokiʻoki i hoʻolaha ʻia i loko o ka ʻōpū liʻiliʻi, e like me nā mea i ʻike ʻia i ka wā duodenal phase III o ke kaʻina hana interdigestive motility.Ua loaʻa kēia pane i ka hapa nui o ka poʻe i komo i ka noiʻi i nā minuke 10-20 mua a ʻike ʻia i ka wā i hāʻawi ʻia ai ka amoxicillin-clavulanate ma mua o ka ʻai.
"ʻO ka hoʻoulu ʻana i kahi preprandial duodenal phase III hiki ke hoʻolalelale i ka transit bowel liʻiliʻi, hoʻoikaika i ka microbiome gut a pāʻani i kahi hana i ka pale ʻana i ka ulu ʻana o ka ulu ʻana o ka maʻi bacterial liʻiliʻi," wahi a Kauka Di Lorenzo.
Ua ʻōlelo ʻo Kauka Di Lorenzo, ʻoi aku ka maikaʻi o ka amoxicillin-clavulanate i nā maʻi me nā hoʻololi o ka duodenal phase III, nā hōʻailona mau o ka pseudo-obstruction o ka ʻōpū a me ka poʻe i hānai pono ʻia i loko o ka ʻōpū liʻiliʻi me ka gastrojejunal nasojejunal feeding tubes a i ʻole surgical jejunostomy.
ʻOiai ʻo ka amoxicillin-clavulanate ka mea e hoʻopilikia nui i ka ʻōpū liʻiliʻi, ʻaʻole maopopo nā hana e hana ai.Ua ʻōlelo pū ʻo Dr. Di Lorenzo, ʻo ka hoʻohana ʻana i ka amoxicillin-clavulanate ma ke ʻano he prokinetic agent, ʻo ia ka hoʻokomo ʻana i ka pale ʻana i ka maʻi bacteria, ʻoi aku ka maikaʻi o nā bacteria gram negative e like me E. coli a me Klebsiella a me ka hoʻoulu ʻana o Clostridium difficile induced colitis.
Eia nō naʻe, ʻōlelo ʻo ia i ka noiʻi hou ʻana i nā pono lōʻihi o ka amoxicillin-clavulanate i nā kūlana lapaʻau gastrointestinal."ʻO ka liʻiliʻi o nā koho therapeutic i loaʻa i kēia manawa hiki ke hōʻoia i ka hoʻohana ʻana i ka amoxicillin-clavulanate i nā poʻe maʻi i koho ʻia me nā ʻano koʻikoʻi o ka dysmotility liʻiliʻi liʻiliʻi ʻaʻole i kūpono nā hana ʻē aʻe," wahi āna.
Ka manawa hoʻouna: Mei-11-2022